Does pretreatment with statins improve clinical outcome after stroke? A pilot case-referent study

Stroke; a Journal of Cerebral Circulation
N Jonsson, K Asplund

Abstract

In primary and secondary prevention trials, statins have been shown to reduce the risk of stroke. In addition to lipid lowering, statins have a number of antiatherothrombotic and neuroprotective properties. In a preliminary observational study, we explored whether clinical outcome is improved in patients who are on treatment with statins when stroke occurs. We conducted a population-based case-referent study of 25- to 74-year-old stroke patients with, for each case of a patient who was on statin treatment at the onset of stroke (n=125), 2 referent patients who were not treated with statins but were matched for age, gender, year of onset, and stroke subtype (n=250). The unadjusted odds ratio for early discharge to home (versus late discharge or death) was 1.41 (95% CI 0.91 to 2.17) when patients on statin treatment were compared with referent stroke patients not on statins. Prognostic factors were, in general, more unfavorable among patients on statins. When this was adjusted for in a logistic regression model, the use of statins was a moderately strong but statistically nonsignificant predictor of discharge to home (multiple-adjusted odds ratio 1.42, 95% CI 0.90 to 2.22). The statistical power of this case-referent study was su...Continue Reading

References

Jan 1, 1988·Acta Medica Scandinavica. Supplementum·K AsplundH Tunstall-Pedoe
Jun 5, 1998·JAMA : the Journal of the American Medical Association·R S Rosenson, C C Tangney
Jan 6, 1999·Journal of Clinical Pharmacy and Therapeutics·R Y Henry, M J Kendall
Oct 8, 1999·Lancet·C D FurbergB M Psaty
Feb 25, 2000·Cerebrovascular Diseases·R Di MascioG Tognoni
May 24, 2000·Neurology·C VautheyJ Bogousslavsky

❮ Previous
Next ❯

Citations

Jul 3, 2013·Archives of Gerontology and Geriatrics·Michael S PhippsLouise D McCullough
May 25, 2002·The British Journal of Surgery·Ian M LoftusM M Thompson
Dec 4, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·P Martínez-SánchezE Díez-Tejedor
Mar 19, 2011·Stroke; a Journal of Cerebral Circulation·Alessandro BiffiNatalia S Rost
Mar 24, 2004·BMC Medicine·Sung Sug YoonAlison E Baird
Dec 6, 2005·Cerebrovascular Diseases·José Vivancos-Mora, Antonio C Gil-Núñez
Oct 10, 2009·Expert Review of Cardiovascular Therapy·David SalatJoan Montaner
Apr 28, 2005·Expert Review of Neurotherapeutics·Majaz Moonis, M Fisher
Oct 12, 2011·Expert Review of Cardiovascular Therapy·Aung K SettAmit K Mistri
Sep 26, 2012·Expert Review of Neurotherapeutics·Irene MiedemaGert-Jan Luijckx
Aug 14, 2009·Expert Review of Neurotherapeutics·Naoki Sawada, James K Liao
Apr 28, 2005·Expert Review of Neurotherapeutics·Joan Montaner
Jan 5, 2002·Expert Opinion on Investigational Drugs·N DelantyN Sheehy
Oct 16, 2012·The American Journal of Geriatric Pharmacotherapy·Clara HjalmarssonBjörn Andersson
Apr 9, 2005·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Matthias Endres
Dec 20, 2005·Neuroimaging Clinics of North America·Aneesh B SinghalMichael A Moskowitz
Aug 19, 2008·International Journal of Stroke : Official Journal of the International Stroke Society·Mitchell S V Elkind
Aug 19, 2008·International Journal of Stroke : Official Journal of the International Stroke Society·Mitchell S V ElkindKen Cheung
Jun 17, 2005·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S AslanyanK R Lees
Oct 13, 2006·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Steven J ShookDerk W Krieger
Mar 26, 2014·Journal of Neurochemistry·Mireia Campos-MartorellJoan Montaner
Jun 5, 2004·Journal of the Neurological Sciences·S GreiseneggerW Lalouschek
Apr 28, 2004·Trends in Neurosciences·Matthias EndresMichael A Moskowitz
Mar 1, 2006·Atherosclerosis. Supplements·Matthias Endres
Apr 25, 2015·AJNR. American Journal of Neuroradiology·N AsdaghiS B Coutts
Dec 9, 2003·Scandinavian Journal of Public Health. Supplement
Oct 31, 2002·Vascular Medicine·I M Loftus, M M Thompson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the Neurological Sciences
Stefan GreiseneggerWolfgang Lalouschek
Stroke; a Journal of Cerebral Circulation
Joan Martí-FàbregasJosep-Lluis Martí-Vilalta
Stroke; a Journal of Cerebral Circulation
K GertzM Endres
Stroke; a Journal of Cerebral Circulation
Majaz MoonisMarc Fisher
© 2021 Meta ULC. All rights reserved